APTO
Aptose Biosciences Inc
NASDAQ: APTO · HEALTHCARE · BIOTECHNOLOGY
$1.71
+0.00% today
Updated 2026-04-30
Market cap
$4.36M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-36.38
Dividend yield
—
52W range
$0 – $0
Volume
—
WallStSmart proprietary scores
16
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C5.0
Quality
C+3.0
Profitability
D5.0
Valuation
C+—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →204 stocks currently score above 75
Price targets
Analyst target
$12.50
+630.99%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
Price chart
X-Ray snapshot
Strengths
Insufficient data
Risks
- Thin margins at 0.00%
- Negative free cash flow $-8.06M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2021 | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | $-65.35M | $-41.82M | $-51.21M | $-25.43M | $-1.58M |
| EPS | — | — | — | — | $-36.38 |
| Free cash flow | $-43.52M | $-32.35M | $-44.62M | $-35.98M | $-8.06M |
| Profit margin | — | — | — | — | — |
Peer comparison
Smart narrative
Aptose Biosciences Inc trades at $1.71. Our Smart Value Score of 16/100 indicates the stock is weak.
Frequently asked questions
What is Aptose Biosciences Inc's stock price?
Aptose Biosciences Inc (APTO) trades at $1.71.
Is Aptose Biosciences Inc overvalued?
Smart Value Score 16/100 (Grade F, Strong Sell).
What is the price target of Aptose Biosciences Inc (APTO)?
The analyst target price is $12.50, representing +631.0% upside from the current price of $1.71.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio—
ROE-694.00%
Beta1.13
50D MA$3.60
200D MA$8.76
Shares out0.00B
Float0.00B
Short ratio—
Avg volume—
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—